Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: Outcomes of therapy in an urban hospital in KwaZulu-Natal

South African Medical Journal

Volumn 102, Issue 12, 2012, Pages 931-935

  Kendon, M ^a   Knight, S E ^a   Ross, A ^a   Giddy, J ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b MCCORD HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ADULT; ANALYTIC METHOD; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KIDNEY DISEASE; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PANCREATITIS; PURE RED CELL ANEMIA; RETROSPECTIVE STUDY; RISK FACTOR; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; TUBERCULOSIS; UREA BLOOD LEVEL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HOSPITALS, URBAN; HUMANS; MALE; RETROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84870678570     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.5574     Document Type: Article

References (15)

1. World Health Organization. TB/HIV Fact Sheet 2011. http://www.who.int/tb/publications/TBHIV_Facts_for_2011.pdf (accessed 16 November 2011).
2. Meintjies PG. When is the optimal time to start ART in patients with TB? Recent findings. Aid for Aids (AfA) Healthcare Professions Newsletter, May 2011. http://www.aidforaids.co.za/newsletters/201105_iss28.pdf (accessed 16 November 2011).
3. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362:697-706. [http://dx.doi.org/10.1056%2FNEJMoa0905848]
4. Department of Health. National Antiretroviral Treatment Guidelines. Pretoria: DoH, 2004. http://southafrica.usembassy.gov/media/2004-doh-art-guidelines.pdf (accessed 16 November 2011).
5. Blanc FX, Soc T, Laureillard D, et al. Significant enhancement of survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral therapy (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: '34% Reduction in Mortality in Early Arm'. Presented at the 18th International AIDS Conference, 18-23 July 2010, Vienna, Austria. http://www.natap.org/2010/IAS/IAS_91.htm (accessed 16 November 2011).
6. Havlir D, Ive P, Kendall M, et al. International randomized trial of immediate vs late ART in HIV+ patients treated for TB: ACTG 5221 STRIDE Study. Presented at the 18th Conference on Retroviruses and Opportunistic Infections, 27 February - 2 March 2011, Boston, Mass. Abstract # 38. http://www.retroconference.org/2011/Abstracts/41152.htm (accessed 16 November 2011).
7. Abdool Karim SS, Naidoo K, Padayatchi N, et al. Optimal timing of ART during TB therapy: Findings of the SAPiT Trial. Presented at the 18th Conference on Retroviruses and Opportunistic Infections, 27 February - 2 March 2011, Boston, Mass. Abstract 39LB. http://retroconference.org/2011/Abstracts/42488.htm (accessed 16 November 2011).
8. Department of Health. Clinical Guidelines for the Management of HIV & AIDS in Adults and Adolescents. Pretoria: DoH, 2010. http://www.fidssa.co.za/Guidelines/2010_Adults_ART_Guidelines.pdf (accessed 16 November 2011).
9. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV infected adults. Int J Tuberc Lung Dis 2005;10(1):31-38. http://www.ingentaconnect.com/content/iuatld/ijtld/2006/00000010/00000001/art00007 (accessed 16 November 2011).
10. Meintjies G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definition for use in resource limited settings. Lancet Infect Dis 2008;8(8):516-523. [http://dx.doi.org/10.1016%2FS1473-3099%2808%2970184-1]
11. World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: Recommendations for HIV-prevalent and resource-constrained settings. 2007, Part 1: 1-7. http://whqlibdoc.who.int/hq/2007/WHO_HTM_TB_2007.379_eng.pdf (accessed 5 December 2011).
12. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004;39(11):1709-1712. [http://dx.doi.org/10.1086%2F425742]
13. Mulenga LB, Kruse G, Lakhi S, et al. Baseline renal insufficiency and risk of death amongst HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 2008;22(14):1821-1827. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649719/pdf/nihms-89912.pdf (accessed 05 December 2011).
14. Russel EC, Charalambous S, Pemba L, Churchyard GJ, Grant AD, Fielding K. Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV programme in South Africa: A cohort study. BMC Public Health 2010;10:433. [http://dx.doi.org/10.1186%2F1471-2458-10-433]
15. Murphy RA, Sunpath H, Taha B, et al. Low uptake of antiretroviral therapy and high mortality after tuberculosis or opportunistic infection in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 2010;14(7):903-908. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207641/pdf/nihms330295.pdf (accessed 5 December 2011).